Search

everythinglearnresearchcommunity

for

Search:↓

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

TNF-alpha inhibitors can cause various immune-related skin issues.

Immune cells affect hair growth and could lead to new hair loss treatments.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

UV radiation causes skin cancer, but sunscreens and certain drugs can help prevent it.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.